MYD88 and ulcer disease: LZD administration significantly decreased the expressions of TLR-2, MyD88, and TNF-α and markedly promoted the generation of duodenal mucosal PGE2, compared to the ulcer control group, thus alleviating duodenal ulcer formation and decreasing the size of ulcers.